- Home
- SPXC vs GRFS Comparison
SPXC vs GRFS Comparison
Compare SPXC & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPXC
- GRFS
- Stock Information
- Founded
- SPXC 1912
- GRFS 1940
- Country
- SPXC United States
- GRFS Spain
- Employees
- SPXC N/A
- GRFS N/A
- Industry
- SPXC Industrial Machinery/Components
- GRFS Biotechnology: Pharmaceutical Preparations
- Sector
- SPXC Industrials
- GRFS Health Care
- Exchange
- SPXC Nasdaq
- GRFS Nasdaq
- Market Cap
- SPXC 7.3B
- GRFS 6.4B
- IPO Year
- SPXC N/A
- GRFS 2006
- Fundamental
- Price
- SPXC $172.72
- GRFS $8.54
- Analyst Decision
- SPXC Hold
- GRFS Sell
- Analyst Count
- SPXC 2
- GRFS 2
- Target Price
- SPXC $142.00
- GRFS $10.50
- AVG Volume (30 Days)
- SPXC 246.9K
- GRFS 1.1M
- Earning Date
- SPXC 10-30-2024
- GRFS 01-01-0001
- Dividend Yield
- SPXC N/A
- GRFS N/A
- EPS Growth
- SPXC 449.97
- GRFS N/A
- EPS
- SPXC 3.72
- GRFS 0.27
- Revenue
- SPXC $1,919,600,000.00
- GRFS $7,814,096,584.00
- Revenue This Year
- SPXC $16.18
- GRFS $8.86
- Revenue Next Year
- SPXC $6.43
- GRFS $7.00
- P/E Ratio
- SPXC $44.29
- GRFS $37.97
- Revenue Growth
- SPXC 12.84
- GRFS 7.21
- 52 Week Low
- SPXC $83.98
- GRFS $5.30
- 52 Week High
- SPXC $173.77
- GRFS $12.15
- Technical
- Relative Strength Index (RSI)
- SPXC 62.22
- GRFS 43.11
- Support Level
- SPXC $160.75
- GRFS $8.27
- Resistance Level
- SPXC $168.40
- GRFS $8.61
- Average True Range (ATR)
- SPXC 5.84
- GRFS 0.37
- MACD
- SPXC 0.96
- GRFS -0.08
- Stochastic Oscillator
- SPXC 96.53
- GRFS 20.22
About SPXC SPX Technologies Inc.
SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The detection and measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company generates majority of its revenue in the United States and rest from China, United Kingdom and other regions.
About GRFS Grifols S.A.
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.